Susquehanna International Group, LLP Nautilus Biotechnology, Inc. Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.34 - $3.39 $50,801 - $73,596	21,710 New	21,710 $64,000
Q2 2023 Aug 11, 2023	SELL	$2.21 - $4.52 $121,375 - $248,242	-54,921 Reduced 56.41%	42,445 $164,000
Q1 2023 May 16, 2023	BUY	$1.67 - $2.77 $122,825 - $203,727	73,548 Added 308.79%	97,366 $269,000
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.47 $20,695 - $32,979	-13,352 Reduced 35.92%	23,818 $42,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.13 $170,612 - $272,457	-87,047 Reduced 70.08%	37,170 $79,000
Q2 2022 Aug 15, 2022	SELL	$2.64 - $4.84 $146,197 - $268,029	-55,378 Reduced 30.83%	124,217 $334,000
Q1 2022 May 16, 2022	BUY	$3.5 - $5.3 $74,700 - $113,117	21,343 Added 13.49%	179,595 $779,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $6.21 $247,388 - $345,232	-55,593 Reduced 26.0%	158,252 $820,000
Q3 2021 Nov 15, 2021	BUY	$6.14 - $10.1 $1.15 Million - $1.89 Million	187,309 Added 705.87%	213,845 $1.31 Million
Q2 2021 Aug 11, 2021	BUY	$9.04 - $14.19 $239,885 - $376,545	26,536 New	26,536 $268,000

64.3M

1.9K

100

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $299M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.